Oculocutaneous albinism type 1

From WikiMD's Food, Medicine & Wellness Encyclopedia

Definition[edit | edit source]

Oculocutaneous albinism type 1 is a condition that affects the coloring of the skin, hair, and eyes.

Alternate names[edit | edit source]

  • OCA1;
  • Oculocutaneous albinism type 1A;
  • OCA1A
Albinisitic man portrait
Albinisitic man portrait

Signs and symptoms[edit | edit source]

Signs and symptoms include very fair skin, white hair, an increased risk for skin damage with sun exposure, reduced vision (sharpness), light colored irises, and photophobia.

Cause[edit | edit source]

It is caused by changes in the TYR gene

Common symptoms[edit | edit source]

80%-99% of people have these symptoms

Less common symptoms[edit | edit source]

30%-79% of people have these symptoms

5%-29% of people have these symptoms

Thickened skin

1%-4% of people have these symptoms

Actinic keratosis

Rare symptoms[edit | edit source]

Inheritance[edit | edit source]

It is inherited in an autosomal recessive pattern.

Diagnosis[edit | edit source]

Diagnosis is through a careful and detailed history, including family history, clinical examination and genetic testing to demonstrate changes in the TYR gene

Chromosome[edit | edit source]

The mutated gene, TYR gene is on chromosome 11.

Treatment[edit | edit source]

There is no cure and treatment is supportive and is based on the patient's presentation.

Oculocutaneous albinism type 1 Resources
Doctor showing form.jpg

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

NIH genetic and rare disease info[edit source]

Oculocutaneous albinism type 1 is a rare disease.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD